NANOWIRES USED AS ENZYME MIMICS
20250244319 ยท 2025-07-31
Inventors
Cpc classification
G01N33/57484
PHYSICS
B01J31/16
PERFORMING OPERATIONS; TRANSPORTING
B82Y40/00
PERFORMING OPERATIONS; TRANSPORTING
B01J31/2226
PERFORMING OPERATIONS; TRANSPORTING
B22F2999/00
PERFORMING OPERATIONS; TRANSPORTING
B82Y5/00
PERFORMING OPERATIONS; TRANSPORTING
B22F9/24
PERFORMING OPERATIONS; TRANSPORTING
B22F1/102
PERFORMING OPERATIONS; TRANSPORTING
B22F2999/00
PERFORMING OPERATIONS; TRANSPORTING
B82Y15/00
PERFORMING OPERATIONS; TRANSPORTING
B22F1/102
PERFORMING OPERATIONS; TRANSPORTING
B01J2231/005
PERFORMING OPERATIONS; TRANSPORTING
International classification
G01N33/543
PHYSICS
B01J23/46
PERFORMING OPERATIONS; TRANSPORTING
B01J31/16
PERFORMING OPERATIONS; TRANSPORTING
Abstract
A class of nanowires that possess enzyme-like catalytic activities, which are termed as enzyme mimics. The morphologies of such enzyme mimics are nanoscale wires (i.e., nanowires) of various lengths, diameters, and degrees of branching and bending. The composition of such enzyme mimics may contain various elements, but at least one is a platinum-group metal [including platinum (Pt), iridium (Ir), rhodium (Rh), palladium (Pd), and/or ruthenium (Ru)]. The nanowires as enzyme mimics can efficiently catalyze multiple chemical reactions that are typically catalyzed by natural enzymes (such as peroxidase, catalase, oxidase, and superoxide dismutase). For example, the nanowires can act as peroxidase mimics and catalyze the oxidation of chromogenic substrates by oxidizing agents (e.g., hydrogen peroxide), yielding colored products. In addition, disclosed here include the applications of such enzyme mimics in biosensing systems, wherein the enzyme mimics arc conjugated to bioreceptors (e.g., antibodies) and are used as labels or reporters.
Claims
1. A nanowire with enzyme-like catalytic activities comprised of at least one platinum-group metal, and a chemical ligand, wherein the chemical ligand is located on the surface of the nanowire.
2. The nanowire of claim 1, wherein the platinum-group metal is selected from the group consisting of platinum (Pt), iridium (Ir), rhodium (Rh), palladium (Pd), or ruthenium (Ru).
3. The nanowire of claim 1, wherein the chemical ligand comprises citrate, polyvinylpyrrolidone, cetyltrimethylammonium chloride/bromide, or polyethylene glycol.
4. The nanowire of claim 1, further comprising one or more non-platinum-group element.
5. The nanowire of claim 1, wherein the nanowire comprises a diameter of less than 100 nm.
6. The nanowire of claim 5, wherein the nanowire comprises a diameter of 2 to 10 nm.
7. The nanowire of claim 1, wherein the nanowire comprises an aspect ratio of greater than 3.
8. The nanowire of claim 1, wherein the enzyme-like activities comprise peroxidase activity, catalase activity, oxidase activity, or superoxide dismutase activity.
9. The nanowire of claim 1, wherein the nanowire is conjugated with a biomolecule.
10. The nanowire of claim 10, wherein the biomolecule comprises an antibody, a protein, a peptide, biotin/avidin, a nucleic acid, or an aptamer.
11. A method for synthesizing a nanowire with catalytic activities comprising combining one or more platinum-group metal precursors and a stabilizer into a solution, stirring said solution under a first condition comprising a first temperature, the first temperature optionally comprising about 130 C., degassing said solution with a flow of nitrogen gas, injecting a reductant into said solution, stirring said solution under a second condition comprising a second temperature, the second temperature optionally comprising about 20 C., and finally collecting and washing the nanowire from said solution.
12. The method of claim 11, wherein the platinum-group metal is selected from the group consisting of platinum (Pt), iridium (Ir), rhodium (Rh), palladium (Pd), or ruthenium (Ru).
13. The method of claim 11, wherein the stabilizer comprises sodium citrate (Na.sub.3CA).
14. The method of claim 13, wherein the Na.sub.3CA has a concentration of 1.7 mg/mL to 11 mg/mL.
15. The method of claim 11, wherein the reductant comprises sodium borohydride (NaBH.sub.4).
16. The method of claim 15, wherein the NaBH.sub.4 has a concentration of 3.8 mg/mL.
17. A biosensing system for an assay comprising the nanowire of claim 9, wherein the biomolecules is a bioreceptor.
18. The system of claim 17, wherein the bioreceptor comprises an antibody, a nucleic acid, an avidin, and an aptamer.
19. The system of claim 17, wherein the assay comprises an ELISA, a western blot, a lateral flow assay, or an immunohistochemistry assay.
20. The system of claim 17, wherein the system senses a biomarker, a chemical, a drug, a virus, or a pathogen.
21. A nanowire with enzyme-like catalytic activities comprised of one or more platinum-group metal, one or more non-platinum-group elements, and a chemical ligand, wherein the chemical ligand is located on the surface of the nanowire.
22. A method of detecting an analyte in a sample, the method comprising exposing the sample to a nanowire of claim 9, wherein the biomolecule is a bioreceptor that senses the analyte or another molecule bound to the analyte.
23. The method of claim 22, wherein the exposing is a step of an ELISA, a western blot, a lateral flow assay, or an immunohistochemistry assay.
Description
BRIEF DESCRIPTION OF THE DRAWINGS
[0003] The present embodiments are illustrated by way of example, and not by way of limitation, in the figures of the accompanying drawings.
[0004] The following figures are illustrative only, and are not intended to be limiting
[0005]
[0006]
[0007]
[0008]
[0009]
[0010]
[0011]
[0012]
[0013]
[0014]
[0015]
[0016]
[0017]
[0018]
[0019]
DEFINITIONS
[0020] Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs. Although any methods and materials similar or equivalent to those described herein can be used in the practice or testing of the invention, the preferred methods and materials are now described. All publications mentioned herein are incorporated herein by reference.
[0021] Generally, nomenclatures used in connection with, and techniques of, cell and tissue culture, molecular biology, immunology, microbiology, genetics, protein, and nucleic acid chemistry and hybridization described herein are those well-known and commonly used in the art. The methods and techniques of the present invention are generally performed according to conventional methods well known in the art and as described in various general and more specific references that are cited and discussed through the present specification unless otherwise indicated.
[0022] The term nanowire generally refers to any elongated nanocrystal or shape that includes at least one cross sectional dimension that is less than 500 nm, and typically, less than 100 nm. In specific examples, nanowires have an aspect ratio (i.e., length to diameter ratio) greater than 3 (>3)
[0023] The term platinum-group metal refers to the six noble, precious metallic elements clustered together in the periodic table. These elements are all transition metals in the d-block (groups 8, 9, and 10, periods 5 and 6). The six platinum-group metals are ruthenium, rhodium, palladium, osmium, iridium, and platinum. They have similar physical and chemical properties, and tend to occur together in the same mineral deposits. However, they can be further subdivided into the iridium-group platinum-group elements (IPGEs: Os, Ir, Ru) and the palladium-group platinum-group elements (PPGEs: Rh, Pt, Pd) based on their behaviour in geological systems.
[0024] The term bioreceptor refers to a biological element (e.g., enzyme, antibody, aptamer, nucleic acid, biotin, avidin etc.) which selectively interacts with or binds to (senses) to another molecule such as an analyte (e.g., enzyme substrate, complementary nucleic acid, antigen). A bioreceptor may interact with a specific analyte of interest to produce an effect measurable by a transducer. High selectivity for the analyte among a matrix of other chemical or biological components is a key requirement of a bioreceptor. Common types of bioreceptor interactions involve: antibody/antigen, enzymes/ligands, nucleic acids/DNA, biotin/avidin, cellular structures/cells, or biomimetic materials. The bioreceptor may be conjugated to a nanowire. Detection of an analyte may involve direct or indirect sensing by a nanowire comprising a bioreceptor. For example, indirect sensing would include use in an assay involving other detection molecule(s) that directly bind to the analyte and the bioreceptor on the nanowire binds to the detection molecule.
[0025] The terms enzyme-like catalytic activity as used herein refers to an artificial enzyme (e.g. nanowire) that mimics the activity of an enzyme.
[0026] The term biomolecule as used herein refers to antibodies, proteins, carbohydrates peptides, lipids, biotin/avidin, nucleic acids, glycoproteins, lipoproteins and glycolipids.
[0027] The term chemical ligand as used herein refers to a molecule on a nanowire that is a remnant of a capping agent or stabilizer that is used in the synthesis of nanowires. For example, citrate is a remnant of use of sodium citrate when combined with a metal precursor during synthesis.
DETAILED DESCRIPTION
[0028] Described herein is a class of nanowires that possess enzyme-like catalytic activities, which will be termed as enzyme mimics in the following. The morphologies of such enzyme mimics are nanoscale wires (i.e., nanowires). The nanowires may be wavy or straight and may have various degrees of branching or have no branches. The composition of such enzyme mimics may contain various elements, but at least one is a platinum-group metal [including platinum (Pt), iridium (Ir), rhodium (Rh), palladium (Pd), and/or ruthenium (Ru)]. As examples, the enzyme mimics may be composed of platinum-group metal(s) only, a mix of platinum-group metal(s) and other metals (e.g., in the forms of alloys and/or core-shell structures), a mix of platinum-group metal(s) and non-metal elements (e.g., in the form of compounds such as metal oxides), and/or a combination of platinum-group metal(s) and other nanostructures/molecules (e.g., in the form of composites). The nanowires as enzyme mimics can efficiently catalyze multiple chemical reactions that are typically catalyzed by natural enzymes. For instance, the nanowires can act as peroxidase mimics and catalyze the oxidation of chromogenic substrates by oxidizing agents (e.g., hydrogen peroxide), yielding colored products..sup.1 The enzyme mimics can be used as alternatives to natural enzymes for a broad range of biomedical applications such as biosensing and diagnostics.
1. Synthesis
[0029] The nanowires are prepared using a solution-phase synthesis, where metal precursors are reduced by sodium borohydride (NaBH.sub.4) as a reductant in the presence of sodium citrate (Na.sub.3CA) as a stabilizer.
[0030] In a specific embodiment, the nanowire is comprised of iridium (Ir). A standard synthetic procedure is described in the following: To a 100 mL-flask, 18 mL deionized water, 2 mL aqueous solution of Na.sub.3IrCl.sub.6.Math.xH.sub.2O (Ir precursor, 4.77 mg/mL), and 3 mL aqueous solution of Na.sub.3CA (4.5 mg/mL) are added. Under magnetic stirring, 12 L of 1 M NaOH solution is added to the flask. The flask is then placed in a 130 C. oil bath under magnetic stirring and is degassed with a flow of nitrogen (N.sub.2) gas for 7 minutes. Then under N.sub.2 blanket, 1 mL aqueous solution of NaBH.sub.4 (3.8 mg/mL, prepared with cold water) is quickly injected to the flask. Immediately after the injection of NaBH.sub.4 solution, the flask is taken out from the oil bath and placed on a stirrer plate. After stirring at room temperature for 45 minutes, the final products (i.e., Ir nanowires) are collected by centrifugation and washed once with deionized water. Finally, the products are re-dispersed in deionized water for future use.
[0031] Nanowires of other metals are synthesized using the same synthetic procedure described for Ir nanowire synthesis, except that: i) the Na.sub.3IrCl.sub.6.Math.xH.sub.2O solution is replaced with solutions of other metal precursors at the same molar concentration; and ii) the concentration of Na.sub.3CA solution may be varied.
[0032] In certain embodiments, Pt, Rh, Pd, IrPt alloyed, and Pt-nickel (Ni) alloyed nanowires (samples in
[0033] Alternative metal precursors may be used for the synthesis of the same nanowires. For multi-metallic nanowires (including bimetallic nanowires), the atomic ratio of metals in the nanowires can be controlled by adjusting the amounts of different metal precursors.
[0034] It should be emphasized that the overall length, degree of branching, and diameter of nanowires can be controlled by adjusting the concentration of Na.sub.3CA or other reagents in the synthetic reaction system (see,
2. Characterizations
i) Morphologies
[0035] Morphologies (including size and shape) of the nanowires are characterized by transmission electron microscopy (TEM) and high-angle annular dark field scanning TEM (HAADF-STEM).
[0036] The morphology of nanowires can also be revealed by HAADF-STEM imaging. In a specific embodiment, the Ir nanowire sample shown in
[0037] The overall length and degree of branching of nanowires could be controlled by adjusting the concentration of Na.sub.3CA solution (or other reagents) in the synthetic system. Taking Ir nanowires as an example, when the concentration of Na.sub.3CA solution in a standard synthesis is increased, the overall length and degree of branching of Ir nanowires are decreased (see
[0038] The diameter of nanowires can be tuned by varying the concentration of Na.sub.3CA solution (or other reagents) in the synthetic system. With Pd nanowires, the average diameters of Pd nanowires can be changed from 8 nm to 5.5 nm and 9 nm (see
ii) Crystal Structures
[0039] Crystal structures of the nanowires are characterized by high-resolution HAADF-STEM and X-ray diffraction (XRD). The results show that the nanowires take a face-centered cubic (fcc) structure. Twin defects can be observed in the nanowires.
[0040] High-resolution HAADF-STEM images of the Ir, Pt, and IrPt alloyed nanowires are shown in
iii) Elemental Compositions
[0041] Elemental compositions of the nanowires are confirmed by XRD (
[0042] For multi-metallic nanowires, elemental composition and distributions of elements in individual nanowires can be analyzed by energy-dispersive X-ray spectroscopy (EDS). For IrPt alloyed nanowires (sample in
iv) Surface Ligands
[0043] The surfaces of the nanowires are absorbed or capped with a remnant of stabilizer, such as citrate, wherein the stabilizer, such as sodium citrate, is initially introduced to the synthetic solution and acts as a colloidal stabilizer. Taking Ir nanowires (sample in
[0044] It should be emphasized that the citrate molecules on nanowire surfaces can be replaced by other chemical ligands (e.g., polyvinylpyrrolidone, cetyltrimethylammonium chloride/bromide, and polyethylene glycol) through various methods (e.g., ligand exchange). In addition, by introducing different chemical ligands as stabilizers or capping agents to the synthetic reaction solution, the nanowires can be capped by various types of ligands on the surfaces..sup.2
3. Enzyme-Like Activities
[0045] In certain embodiments, the nanowires possess enzymatic mimetic activity, such as peroxidase-like catalytic activities..sup.1 Specifically, in certain embodiments, the nanowires can effectively catalyze the oxidation of peroxidase substrates [e.g., 3,3,5,5-tetramethylbenzidine, TMB; 3,3-diaminobenzidine, DAB; o-phenylenediamine, OPD; and 2,2-Azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) diammonium salt, ABTS] by oxidizing agents (e.g., hydrogen peroxide), yielding colored products. See more details in
[0046] In addition to peroxidase, the nanowires possess similar catalytic activities of other enzymes such as catalase, oxidase, and superoxide dismutase. In certain embodiments, the nanowires of different metals (samples shown in
4. Conjugation with Biomolecules
[0047] The nanowires can be conjugated with various biomolecules (e.g., antibodies, proteins, peptides, biotin/avidin, and nucleic acids) through covalent methods (e.g., metal-thiolate bonding-mediated couplings) and/or non-covalent methods (e.g., electrostatic and hydrophobic interactions)..sup.3,4 In a specific embodiment directed to conjugation of antibodies with a non-covalent method, a typical procedure is described in the following:
[0048] An aqueous suspension of nanowires is adjusted, if needed, to pH 8-10 with carbonate-bicarbonate buffer or NaOH. Then, certain amount of antibody is added to the nanowire suspension. After 1-hour incubation at room temperature, a quantity of 5% bovine serum albumin (BSA) is added to the suspension. After 2-hour incubation, the nanowire-antibody conjugates are collected by centrifugation and washed twice by phosphate-buffered saline (PBS, pH 7.4) buffer. Finally, the conjugates are re-dispersed in PBS containing 1% BSA and 0.02% NaN.sub.3 for future use. The loading amount of antibodies on nanowires can be adjusted by varying the ratio of nanowires and antibodies used in the conjugation.
5. Applications in Biosensing
[0049] In certain embodiments, nanowires can be conjugated with a bioreceptor. When conjugated with bioreceptors (e.g., antibodies, nucleic acids, and aptamers), the nanowires can be used as labels or reporters for various biosensing and diagnostic applications such as enzyme-linked immunosorbent assay (ELISA), western blotting, lateral flow assay, and immunohistochemistry..sup.1 The nanowires-based assays can be used for sensing various types of analytes, such as biomarkers, chemicals, drugs, virus, and pathogens, as long as appropriate bioreceptors are available.
[0050] Taking ELISA platform as a model biosensing system,
EXAMPLES
Example 1. Ir Nanowires-Catalyzed Reactions
[0051]
[0052] Taking TMB as a model substrate, the catalytic reaction yielded a blue-colored product (i.e., oxidized TMB) with a maximum absorbance at 653 nm (see
[0053] The peroxidase-like catalytic efficiency of nanowires can be determined by the steady-state kinetic assays, where oxidation of TMB by H.sub.2O.sub.2 is used as a model reaction..sup.5 Using Ir nanowires (sample shown in
[0054] All the assays were conducted in 1.0-mL cuvettes (path length, L=1.0 cm) and 0.2 M NaOAc/HOAc buffer, pH 4.0.5 In a typical assay, Ir nanowires (final concentration in reaction solution=1.0 ng/mL. Note ng refers to nanogram or 10.sup.9 gram) were mixed with 2.0 M H.sub.2O.sub.2 and TMB of various concentrations in the buffer solution. The absorbance of reaction solution at .sub.max=653 nm was immediately recorded by a UV-vis spectrophotometer with an interval of 2 seconds for 1 minute. The Absorbance versus Time curve was obtained, which was then used to derive the initial reaction velocity () through the equation: =Slope.sub.initial/(.sub.TMS-653 nmL). Herein, Slope.sub.initial is the first derivation from the initial point on the measured curve, .sub.TMB-653 nm is the molar extinction coefficient of oxidized TMB at 653 nm (3.910.sup.4 M.sup.1.Math.cm.sup.1) and L is the path length (1.0 cm). Then, the plot of initial reaction velocity () against TMB concentration (see
[0055] From the plot shown in
Example 2. Nanowire-Based ELISA
[0056] Using carcinoembryonic antigen (CEA, a cancer biomarker) as a model analyte, a typical procedure of nanowires-based ELISA is described in the following: A 96-well microtiter plates was coated with rabbit anti-CEA polyclonal antibody (corresponding to the capture antibody in
[0057] For comparison, HRP-based ELISA using the same set of antibodies was also performed. The assay procedure and materials of HRP-based ELISA were kept the same as the nanowires-based ELISA, except for the substitutions of nanowire-goat anti-mouse IgG conjugates with HRP-goat anti-mouse IgG conjugates and the change of substrate solution to citric acid/Na.sub.2HPO.sub.4 buffer pH 5.0, containing 0.8 mM TMB and 5 mM H.sub.2O.sub.2.
[0058]
[0059] Pt nanowires-, IrPt nanowires-, PtNi nanowires-, and Rh nanowires-based ELISAs of CEA standards were performed in separate experiments. Their calibration curves are shown in
REFERENCES
[0060] 1. Wei, Z.; Xi, Z.; Vlasov, S.; Ayala, J.; Xia, X. Nanocrystals of platinum-group metals as peroxidase mimics for in vitro diagnostics. Chemical Communications, 2020, 56, 14962-14975. [0061] 2. Yang, T.; Shi, Y.; Janssen, A.; Xia, Y. Surface capping agents and their roles in shape-controlled synthesis of colloidal metal nanocrystals. Angewandte Chemie International Edition, 2020, 59, 15378-15401. [0062] 3. Sperling, R. A.; Parak, W. J. Surface modification, functionalization and bioconjugation of colloidal inorganic nanoparticles. Philosophical Transactions: Mathematical, Physical and Engineering Sciences, 2010, 368, 1333-1383. [0063] 4. Jazayeri, M. H.; Amani, H.; Pourfatollah, A. A.; Pazoki-Toroudi, H.; Sedighimoghaddam, B. Various methods of gold nanoparticles (GNPs) conjugation to antibodies. Sensing and Bio-Sensing Research, 2016, 9, 17-22. [0064] 5. Xia, X.; Zhang, J.; Lu, N.; Kim, M.; Ghale, K.; Xu, Y.; McKenzie, E.; Liu, J.; Ye, H. PdIr core-shell nanocubes: a type of highly efficient and versatile peroxidase mimic. ACS Nano, 2015, 9, 9994-10004.